Entropion Treatment Market Size & Share, by Type (Congenital, Paralytic); Treatment (Artificial Tears, Skin Tape, Anti-inflammatory Drugs, Surgery); End-user (Specialty Clinics, Hospital) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3777
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Entropion Treatment Landscape

top-features-companies
    • Alembic Limited
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eli Lilly and Company
    • Bausch & Lomb Incorporated
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Sanofi-aventis Groupe
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Bausch & Lomb Incorporated, announced the launch of hydration boost lubricant eye drops and micellar eyelid cleansing wipes, under the brand name BioTrue.

  • Novartis AG to acquire Vedere Bio, in order to expand its portfolio to ophthalmology and opto-genetic gene therapy technology for treating blindness.

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3777
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing geriatric population, rising success of the entropion treatment, the growing popularity of contact lenses, and increasing cases of dry eye syndrome are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 14% over the forecast period, i.e., 2023-2035.

Lack of awareness regarding ophthalmic disorders and complications in surgery are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, treatment, end user, and by region.

The surgery segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying